Zicam

Zicam is a prominent consumer healthcare brand specializing in over-the-counter (OTC) remedies for the common cold, allergies, and sinus congestion. Originally developed and marketed by Matrixx Initiatives, the brand was acquired by Church & Dwight in 2020 for approximately $530 million. Zicam is most recognized for its 'Cold Remedy' line, which utilizes zinc-based formulations—specifically zinc gluconate and zinc acetate—intended to reduce the duration and severity of cold symptoms. The brand's product delivery formats include nasal swabs, oral mists, and rapid-dissolve tablets. Zicam maintains a significant market share in the cough and cold category within the United States retail market.